British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC V6Z1Y6, Canada.
Prev Sci. 2011 Jun;12(2):173-80. doi: 10.1007/s11121-010-0197-y.
The purpose of this study was to determine the incidence and predictors of initiating methamphetamine injection among a cohort of injection drug users (IDU). We conducted a longitudinal analysis of IDU participating in a prospective study between June 2001 and May 2008 in Vancouver, Canada. IDU who had never reported injecting methamphetamine at the study's commencement were eligible. We used Cox proportional hazards models to identify the predictors of initiating methamphetamine injection. The outcome was time to first report of methamphetamine injection. Time-updated independent variables of interest included sociodemographic characteristics, drug use patterns, and social, economic and environmental factors. Of 1317 eligible individuals, the median age was 39.9 and 522 (39.6%) were female. At the study's conclusion, 200 (15.2%) participants had initiated injecting methamphetamine (incidence density: 4.3 per 100 person-years). In multivariate analysis, age (adjusted hazard ratio [aHR]: 0.96 per year older, 95%CI: 0.95-0.98), female sex (aHR: 0.58, 95%CI: 0.41-0.82), sexual abuse (aHR: 1.63, 95%CI: 1.18-2.23), using drugs in Vancouver's drug scene epicentre (aHR: 2.15 95%CI: 1.49-3.10), homelessness (aHR: 1.43, 95%CI: 1.01-2.04), non-injection crack cocaine use (aHR: 2.06, 95%CI: 1.36-3.14), and non-injection methamphetamine use (aHR: 3.69, 95%CI: 2.03-6.70) were associated with initiating methamphetamine injection. We observed a high incidence of methamphetamine initiation, particularly among young IDU, stimulant users, homeless individuals, and those involved in the city's open drug scene. These data should be useful for the development of a broad set of interventions aimed at reducing initiation into methamphetamine injection among IDU.
本研究旨在确定注射吸毒者(IDU)队列中开始使用甲基苯丙胺注射的发生率和预测因素。我们对 2001 年 6 月至 2008 年 5 月期间在加拿大温哥华参加前瞻性研究的 IDU 进行了纵向分析。在研究开始时从未报告过使用甲基苯丙胺注射的 IDU 符合条件。我们使用 Cox 比例风险模型来确定开始使用甲基苯丙胺注射的预测因素。结果是首次报告使用甲基苯丙胺注射的时间。感兴趣的时间更新独立变量包括社会人口特征、药物使用模式以及社会、经济和环境因素。在 1317 名合格的个体中,中位年龄为 39.9 岁,522 名(39.6%)为女性。在研究结束时,200 名(15.2%)参与者开始注射甲基苯丙胺(发生率密度:每 100 人年 4.3 例)。在多变量分析中,年龄(调整后的危险比[ahr]:每增加 1 岁为 0.96,95%ci:0.95-0.98)、女性(ahr:0.58,95%ci:0.41-0.82)、性虐待(ahr:1.63,95%ci:1.18-2.23)、在温哥华毒品现场中心使用毒品(ahr:2.15 95%ci:1.49-3.10)、无家可归(ahr:1.43,95%ci:1.01-2.04)、非注射可卡因(ahr:2.06,95%ci:1.36-3.14)和非注射甲基苯丙胺(ahr:3.69,95%ci:2.03-6.70)与开始使用甲基苯丙胺注射有关。我们观察到甲基苯丙胺使用率很高,特别是在年轻的 IDU、兴奋剂使用者、无家可归者和参与城市开放毒品现场的人群中。这些数据对于制定一套广泛的干预措施以减少 IDU 中甲基苯丙胺注射的开始使用应该是有用的。